To reduce the FDA’s authority would be unwise. Yet patients with devastating diagnoses should have faster access to experimental drugs.
from Forbes – Tech http://ift.tt/29nf9rp
via IFTTT
To reduce the FDA’s authority would be unwise. Yet patients with devastating diagnoses should have faster access to experimental drugs.
from Forbes – Tech http://ift.tt/29nf9rp
via IFTTT